As of September 12, 2026, two major developments have moved past what this article covers. On June 25, 2026, the U.S. Supreme Court ruled 7-2 in Monsanto Co. v. Durnell that federal pesticide law (FIFRA) preempts state-law failure-to-warn claims against Roundup, cutting off that legal theory for future individual lawsuits. Separately, Bayer’s proposed $7.25 billion nationwide class settlement (King v. Monsanto, St. Louis Circuit Court) — covering roughly 65,000 pending cases plus future claimants exposed before February 17, 2026 — has its final fairness hearing scheduled for September 14, 2026 before Judge Timothy Boyer, after two postponements tied to a wave of opt-out reversals following the Durnell ruling. No immediate ruling is expected at that hearing. Estimated individual payouts under the settlement range from about $6,000 to more than $165,000, paid out over up to 21 years.
Last updated: September 2026
Tens of thousands of Roundup cancer lawsuits are still moving through the courts in 2026, and claimants are closer than ever to final resolution. The Roundup lawsuit update for this year is significant. Bayer continues to fight on multiple legal fronts, but mounting court losses and ongoing trials are keeping the pressure on.
If you or someone you love developed cancer after using Roundup, this article covers everything you need to know. You will find out who qualifies, what settlements look like, how much people are getting paid, and what the courts have ruled recently.
One figure sets the stage: Bayer has already committed over $11 billion toward resolving Roundup claims. Despite that, litigation is still active and new claims are being filed.
Here is exactly what this article covers, from the latest court rulings to the step-by-step filing process.
Roundup Lawsuit Update 2026: Where Things Stand Right Now
The Roundup lawsuit in 2026 is one of the largest active mass tort cases in U.S. legal history. Bayer AG, which acquired Monsanto in 2018, faces tens of thousands of individual claims from people who say Roundup’s active ingredient, glyphosate, caused their cancer.
As of early 2026, roughly 30,000 to 50,000 cases remain unresolved in state and federal courts. That number fluctuates as new claims enter and settlements close out older ones.
The central question before the courts has not changed: did Monsanto fail to warn consumers that Roundup could cause cancer? Juries have repeatedly said yes.
2026 Status Snapshot:
| Data Point | Current Status |
|---|---|
| Total claims filed | Estimated 100,000+ historically |
| Claims still active | 30,000 to 50,000 estimated |
| Bayer settlement commitment | $11 billion+ |
| Key pending issue | Supreme Court preemption question |
| New claims still accepted | Yes, ongoing |
Bayer’s strategy in 2026 involves a two-track approach. The company continues settling individual cases quietly while simultaneously pushing a federal preemption argument to shield it from future punitive damages.
That preemption argument is the wildcard for 2026. If the U.S. Supreme Court sides with Bayer, it could dramatically reduce future payout totals.
What Is the Latest News on the Roundup Lawsuit This Year
The latest Roundup lawsuit news in 2026 centers on Bayer’s ongoing push to get federal courts to block state-level failure-to-warn claims. This is the most watched legal development of the year.
In prior years, the Ninth Circuit Court of Appeals rejected Bayer’s preemption defense. Bayer appealed. The fate of that appeal, and whether it reaches the Supreme Court, directly affects how much money future claimants can recover.
Separately, individual trials continue producing large jury verdicts against Bayer.
Recent Key Developments:
- Bayer lost multiple bellwether trials between 2023 and 2025, with juries awarding $25 million to $2.25 billion in various cases before judicial reductions
- The Ninth Circuit has consistently upheld the right of plaintiffs to sue under state law
- California state courts remain particularly hostile to Bayer’s defenses
- New scientific studies released in 2024 and 2025 continue strengthening the glyphosate-cancer link
The news cycle in 2026 is being shaped by whether Bayer can finally secure a legal escape route through preemption, or whether it must continue settling cases one by one.
Plaintiffs’ attorneys say Bayer has no good options. Settling is expensive. Going to trial is expensive. And losing on preemption arguments is looking increasingly likely.
Is the Roundup Lawsuit Still Active in 2026
Yes, the Roundup lawsuit is absolutely still active in 2026. This is not a closed case. New claims are being accepted.
Some people assume that because Bayer announced a multi-billion-dollar settlement back in 2020, the case is over. It is not. That 2020 announcement resolved a portion of existing claims. It did not end all litigation.
Thousands of plaintiffs who did not opt into the original settlement fund are still in active litigation. People who developed cancer more recently are filing new claims.
Think of it like a river that never stops flowing. Some cases close. New ones open. The litigation pipeline stays full.
Why Litigation Continues:
- Not all original claimants accepted settlement terms
- New cancer diagnoses linked to past Roundup exposure keep arriving
- Bayer has not agreed to stop fighting liability entirely
- State courts maintain independent jurisdiction over new claims
- The preemption legal battle has delayed final resolution
Courts in California, Missouri, and other states are scheduling new trials throughout 2026. Plaintiffs’ attorneys are actively recruiting new clients with documented cancer diagnoses and Roundup exposure histories.
This case will not wrap up cleanly in one announcement. It is a rolling, multi-year process.
Key Takeaway: The Roundup lawsuit is still fully active in 2026, with tens of thousands of cases unresolved and new claims still being accepted by plaintiffs’ attorneys nationwide.
Roundup Lawsuit Status 2026: Courts, Appeals, and Key Rulings
The legal status of the Roundup lawsuit in 2026 is shaped by three overlapping battlegrounds: federal MDL proceedings, state court trials, and the appellate courts.
The federal multidistrict litigation (MDL) is managed in the Northern District of California. Judge Vince Chhabria has presided over that MDL, which consolidated thousands of federal cases for coordinated pretrial proceedings.
Key Cases That Shaped the 2026 Landscape:
| Case | Court | Outcome |
|---|---|---|
| Johnson v. Monsanto | California Superior Court | Plaintiff won; $289 million reduced to $78 million |
| Hardeman v. Monsanto | Federal, N.D. California | Plaintiff won; $80 million verdict upheld on appeal |
| Pilliod v. Monsanto | California Superior Court | Plaintiffs won; $2.055 billion punitive damages later reduced |
These three bellwether cases set the tone. Juries believed the plaintiffs. Juries punished Monsanto.
In 2026, the appellate questions focus on punitive damages caps and the federal preemption argument. Bayer wants the Supreme Court to rule that EPA’s position on glyphosate safety preempts state-level failure-to-warn claims. That ruling, if it comes, would be seismic.
The Ninth Circuit has already rejected preemption twice. Bayer keeps pushing. The outcome of any Supreme Court review remains the biggest unknown in the 2026 Roundup legal landscape.
Roundup Cancer Lawsuit Update: What the Science Now Shows
The Roundup cancer lawsuit is built on a scientific foundation that keeps getting stronger. The core claim is that glyphosate, Roundup’s active ingredient, causes non-Hodgkin lymphoma and potentially other blood cancers.
The International Agency for Research on Cancer (IARC) classified glyphosate as “probably carcinogenic to humans” back in 2015. That classification has not changed.
More recent research published between 2022 and 2025 has reinforced the connection, particularly for people with long-term or occupational exposure.
Scientific Consensus Points:
- IARC Group 2A classification: probably carcinogenic to humans
- Strongest evidence links glyphosate to non-Hodgkin lymphoma
- Occupational exposure (farmers, landscapers) carries the highest documented risk
- Studies show DNA damage and oxidative stress in cells exposed to glyphosate
- Animal studies consistently show tumor development at exposure levels relevant to humans
The EPA’s position is the main counterpoint. The agency has maintained that glyphosate is “not likely to be carcinogenic.” Bayer leans on the EPA stance hard in court.
But juries have repeatedly chosen to trust the IARC science and the plaintiffs’ medical experts over the EPA’s regulatory position. That gap between agency approval and jury verdicts is the engine driving this entire litigation forward.
Roundup Glyphosate Lawsuit Update: The Chemical at the Center of It All
Glyphosate is the world’s most widely used herbicide. Roundup is the best-known product containing it. The glyphosate lawsuit update in 2026 reflects an ongoing battle over what that chemical does inside the human body.
Monsanto developed glyphosate in the 1970s. By the 1990s and 2000s, it was being sprayed on hundreds of millions of acres annually across the U.S., particularly on genetically modified “Roundup Ready” crops.
Homeowners, gardeners, landscapers, farmers, and agricultural workers were all exposed.
Glyphosate Exposure by Category:
| User Type | Typical Exposure Level | Lawsuit Eligibility |
|---|---|---|
| Farmers and agricultural workers | High, daily or seasonal | Strong claim basis |
| Landscapers and groundskeepers | Moderate to high | Strong claim basis |
| Homeowners, garden users | Low to moderate | Qualifying with diagnosis |
| Golf course workers | Moderate | Qualifying with diagnosis |
| Children of exposed individuals | Secondary exposure | Case-by-case basis |
The 2026 glyphosate lawsuit landscape includes emerging arguments about reformulation. Bayer launched a glyphosate-free version of Roundup for residential use. Plaintiffs’ attorneys call that move an implicit acknowledgment of the danger.
That reformulation argument is being used in new 2026 cases to argue that Bayer knew the risk and acted on it for profit reasons, not safety ones.
Key Takeaway: Glyphosate remains the central scientific and legal battleground in 2026, with plaintiffs using Bayer’s own product reformulation decision as evidence the company understood the cancer risk.
Roundup Lawsuit Non-Hodgkin Lymphoma Claims: Who Is Most Affected
Non-Hodgkin lymphoma (NHL) is the cancer most directly connected to Roundup exposure in court cases. It is the primary diagnosis that forms the backbone of most successful claims.
NHL is a category of blood cancers that begins in the lymphatic system. It includes several subtypes. Courts have accepted claims involving multiple NHL subtypes, but some carry stronger evidentiary support than others.
NHL Subtypes Covered in Roundup Claims:
| Cancer Type | Evidence Strength | Claim Viability |
|---|---|---|
| Diffuse Large B-Cell Lymphoma (DLBCL) | Very strong | High |
| Follicular Lymphoma | Strong | High |
| Chronic Lymphocytic Leukemia (CLL) | Moderate to strong | Moderate to high |
| Mantle Cell Lymphoma | Moderate | Moderate |
| Marginal Zone Lymphoma | Moderate | Moderate |
| T-Cell Lymphoma | Emerging | Case-by-case |
Most of the landmark verdicts, including Johnson, Hardeman, and Pilliod, involved plaintiffs diagnosed with NHL. Those cases set the legal precedent that plaintiff attorneys now build on.
If you were diagnosed with NHL and have a documented history of Roundup use, your claim has a strong foundation. How strong depends on your specific diagnosis subtype, duration of exposure, and how early or late your cancer was detected.
Who Qualifies for the Roundup Lawsuit in 2026
You may qualify for the Roundup lawsuit if you used Roundup or a glyphosate-based product and were later diagnosed with non-Hodgkin lymphoma or a related blood cancer. Those are the two core requirements.
Beyond those basics, attorneys look at several additional factors to assess claim strength.
Roundup Lawsuit Eligibility Checklist:
| Eligibility Factor | Details |
|---|---|
| Cancer diagnosis | Non-Hodgkin lymphoma is primary; other blood cancers reviewed |
| Roundup or glyphosate product use | Must have used the product before diagnosis |
| Exposure duration | Longer exposure generally strengthens the claim |
| Time since diagnosis | Statute of limitations applies; do not wait |
| Medical records available | Documentation required for claim filing |
| Year of exposure | Claims go back decades; no cutoff on exposure year |
Family members of someone who died from NHL after Roundup exposure may qualify to file a wrongful death claim. Estates of deceased claimants can file in most states.
You do not need to be a professional applicator. Homeowners who used Roundup on their lawns and gardens qualify if they developed NHL.
One important note: people who already received a settlement through Bayer’s 2020 fund signed releases. Those releases may prevent them from filing additional claims, depending on the terms of their specific agreement.
Roundup Lawsuit Settlement 2026: What Has Been Agreed So Far
The Roundup lawsuit settlement history is extensive. The biggest milestone came in June 2020, when Bayer announced a settlement framework of approximately $10.9 billion to resolve the majority of existing claims at the time.
That amount was split across several components, covering settled cases, future claims, and a fund for claimants who had not yet been diagnosed.
Roundup Settlement Fund Overview:
| Settlement Component | Approximate Amount |
|---|---|
| Resolved existing claims | $8.8 billion |
| Potential future claimants | $1.25 billion |
| MDL case resolution | Included in total |
| Class action settlement attempts | Rejected by courts |
Not everything went smoothly. Federal Judge Chhabria rejected a proposed class action settlement in 2021 that would have capped future claims. He said the proposed deal did not adequately protect future claimants.
That rejection means people diagnosed with NHL in 2022, 2023, 2024, 2025, and 2026 can still pursue full individual claims. They are not capped by any prior deal.
In 2026, Bayer continues negotiating individual case settlements while managing active trials. The company’s preference is to avoid more jury trials, given how badly those have gone historically.
Key Takeaway: Bayer’s 2020 settlement covered a portion of existing claims, but the failed class action attempt means tens of thousands of future claimants retain their full legal rights in 2026.
Bayer Roundup Settlement News 2026: What Bayer Is Doing Now
Bayer’s legal strategy in 2026 is a calculated combination of aggressive settlement, vigorous appeals, and a long-shot bid for Supreme Court intervention. The company is playing multiple angles at once.
Bayer has publicly stated it believes glyphosate is safe and that the science does not support a cancer link. At the same time, the company keeps writing settlement checks. Those two positions do not align. Plaintiffs’ attorneys point to that contradiction constantly.
Bayer’s 2026 Legal Moves:
- Continuing to quietly settle individual cases outside of trial
- Pursuing federal preemption argument to block future state court claims
- Appealing punitive damage awards in cases it has lost
- Lobbying Congress and the EPA to strengthen regulatory support for glyphosate
- Launching a revised Roundup formula for residential use without glyphosate
Bayer’s shares have taken significant hits since the Roundup litigation exploded. The company had a market cap of around 63 billion euros before the Monsanto acquisition. That figure dropped dramatically as the scale of legal liability became clear.
Bayer CEO Bill Anderson has spoken publicly about wanting to put the Roundup litigation behind the company. But as of 2026, that goal remains elusive.
The company estimates its total Roundup liability exposure could range from $11 billion on the low end to as high as $16 billion or more, depending on how remaining cases resolve.
Roundup Lawsuit Payout Amounts 2026: Estimated Compensation Ranges
Roundup lawsuit payout amounts in 2026 vary significantly based on cancer type, exposure history, diagnosis severity, and whether a case settles or goes to trial. There is no single fixed number.
Individual settlements are typically confidential. But the landscape of jury verdicts and publicly disclosed settlement ranges gives a reasonable picture.
Roundup Payout Estimate Ranges:
| Claim Scenario | Estimated Payout Range |
|---|---|
| Mild NHL, early diagnosis, settled early | $50,000 to $150,000 |
| Moderate NHL, significant treatment, settled | $150,000 to $500,000 |
| Severe NHL, long treatment, serious disability | $500,000 to $2 million+ |
| Wrongful death claim, family filing | $250,000 to $1 million+ |
| Jury verdict (before appeals and reductions) | $25 million to $2.25 billion |
| Post-reduction jury award (typical) | $5 million to $75 million |
Attorney fees in mass tort cases typically run 33% to 40% of the gross recovery. That is worth factoring into any estimate.
Cases that settle without trial resolve faster and for less money. Cases that go to trial take longer but can result in dramatically higher awards, especially if punitive damages are applied.
No attorney can guarantee a specific payout. These ranges reflect historical case data. Your case depends on your unique facts.
How Much Will Roundup Claimants Receive From a Settlement or Verdict
How much you personally receive depends on a point system that most mass tort programs use. It weighs multiple factors to arrive at your specific claim value.
Think of it like insurance pricing: same risk category, different individual circumstances, different final number.
Factors That Affect Individual Payout:
- Cancer subtype and severity at diagnosis
- Length and intensity of Roundup exposure
- Age at diagnosis
- Medical expenses incurred
- Lost income and lost earning capacity
- Pain and suffering evidence
- Whether the cancer has gone into remission or is ongoing
- Whether the claim settles or goes to a jury
Claimants who can prove heavy occupational exposure, like farmers who sprayed Roundup for years, tend to receive higher amounts than casual homeowners who used it a few times per year.
That said, even moderate-use claimants with serious NHL diagnoses have received significant settlements.
Key Takeaway: Your individual Roundup payout depends on cancer severity, exposure history, and claim documentation, with settlement amounts ranging from tens of thousands to several million dollars depending on case strength.
Roundup Class Action vs Mass Tort: What You Need to Know
The Roundup lawsuit is a mass tort, not a traditional class action. This distinction matters a lot for what you receive and how your case is handled.
In a class action, all plaintiffs share one pool of money and receive roughly equal amounts. In a mass tort, each plaintiff has their own individual claim with their own potential payout based on their specific circumstances.
Class Action vs Mass Tort Comparison:
| Feature | Class Action | Mass Tort |
|---|---|---|
| Individual payout | Shared equally | Based on individual facts |
| Case control | Attorneys control | You have more input |
| Speed | Faster in theory | Can take longer |
| Payout potential | Lower per person | Higher per person |
| Legal coordination | Single filing | Coordinated but individual |
| Roundup lawsuit type | Not applicable | This is a mass tort |
Because Roundup is a mass tort, you need your own attorney representing your specific claim. You are not automatically included just because you used the product.
Federal Judge Chhabria’s rejection of the proposed class action settlement in 2021 confirmed that the Roundup litigation would remain in mass tort format. That is better for individual claimants who suffered seriously.
Mass torts are consolidated in an MDL for pretrial efficiency, but each case retains its individual identity for trial and settlement purposes.
How to File a Roundup Lawsuit Claim in 2026
Filing a Roundup lawsuit claim in 2026 starts with connecting with a qualified mass tort attorney. There is no government form to fill out online. This is a private civil litigation process.
Here is how the process works from start to finish.
Step-by-Step Filing Process:
- Initial consultation: Contact a mass tort law firm that handles Roundup cases. Most offer free consultations.
- Case intake review: The attorney reviews your medical records, diagnosis, and Roundup exposure history.
- Retainer agreement: You sign a contingency fee agreement, meaning no upfront cost to you.
- Case investigation: The firm gathers medical records, bills, purchase receipts, employment records, and exposure documentation.
- Complaint filed: The attorney files your lawsuit in the appropriate court, often joined to the federal MDL.
- Discovery phase: Both sides exchange documents, depose witnesses, and retain medical experts.
- Settlement or trial: The case resolves through negotiated settlement or proceeds to a jury trial.
What You Need to Gather:
- Medical records confirming your NHL or blood cancer diagnosis
- Records of Roundup purchases or use (receipts, photos, employer records)
- Employment records if exposed through work
- Treatment records and bills
- Names of doctors who treated you
The earlier you start, the better. Statutes of limitations can close the door on valid claims.
Roundup Lawsuit Deadline 2026: Do Not Miss These Key Dates
The Roundup lawsuit deadline in 2026 is not one fixed date for everyone. Statutes of limitations vary by state and by individual circumstances. But waiting is dangerous.
Most states give personal injury plaintiffs two to three years from the date they knew or should have known their cancer was linked to Roundup. That clock is different for everyone.
Statute of Limitations by State (Examples):
| State | Time Limit | Notes |
|---|---|---|
| California | 2 years | From date of discovery |
| Missouri | 5 years | From date of injury |
| Texas | 2 years | From date of discovery |
| New York | 3 years | From date of injury |
| Florida | 4 years | From date of discovery |
| Illinois | 2 years | From date of discovery |
“Discovery” means when you knew or should have known that Roundup may have caused your cancer. In some cases, that is the date of diagnosis. In others, it is the date a doctor specifically linked your illness to chemical exposure.
Important 2026 Deadlines to Know:
- New claims are still being accepted as of early 2026
- Claimants diagnosed in 2023 and 2024 may be approaching their filing window
- Wrongful death claims have separate filing timelines
Do not assume you have missed the deadline without speaking to an attorney. Discovery rules can extend your window in ways that are not obvious.
Latest on Roundup Lawsuit: What Comes Next for Claimants
The latest on the Roundup lawsuit points toward a 2026 that will be defined by appellate outcomes, continued individual settlements, and the unresolved preemption battle. No dramatic single resolution is expected this year.
Bayer wants closure. Plaintiffs’ attorneys want to keep the pressure on through trials. Courts want to move dockets. These competing interests create a predictable outcome: ongoing, case-by-case resolution for the foreseeable future.
What Claimants Can Expect in 2026:
| Development | Likelihood | Impact on Claimants |
|---|---|---|
| Continued individual settlements | Very high | Most cases resolve this way |
| New jury trials in state courts | High | Potential for large verdicts |
| Supreme Court preemption review | Moderate | Could cap future claims if granted |
| New legislation limiting claims | Low | Unlikely in current political climate |
| Bayer seeking global resolution | Possible | Would accelerate closure for all |
For people already in litigation, 2026 is a year to work closely with your attorney and track case progress. Settlement offers may come. Understanding how to evaluate them is critical.
For people who have not yet filed, 2026 may be one of your last realistic windows before statutes of limitations close on older exposure claims.
The Roundup litigation has now lasted nearly a decade since the first verdicts in 2018. It will not end overnight. But momentum continues to favor plaintiffs who have properly documented their claims and are working with experienced mass tort counsel.
Key Takeaway: The 2026 Roundup lawsuit outlook favors continued settlements and active trials, with the Supreme Court preemption question as the biggest wildcard that could reshape the entire litigation going forward.
Frequently Asked Questions
What is the current status of the Roundup lawsuit in 2026?
The Roundup lawsuit is still active in 2026, with an estimated 30,000 to 50,000 claims still unresolved.
Bayer continues settling individual cases while also pursuing a federal preemption defense in appellate courts.
New claims are still being accepted by plaintiffs’ attorneys nationwide.
How much money can I get from a Roundup settlement?
Individual settlements typically range from $50,000 for mild cases to over $2 million for severe or terminal cases.
The exact amount depends on your cancer type, severity, length of Roundup exposure, and your medical expenses.
Jury verdicts have reached much higher amounts before judicial reductions on appeal.
Do I qualify for the Roundup lawsuit if I was only an occasional user?
Occasional users who developed non-Hodgkin lymphoma may still qualify for the Roundup lawsuit.
Eligibility is based on your cancer diagnosis and documented Roundup use, not frequency alone.
An attorney can review your specific exposure history and medical records to assess your claim.
What cancers are covered by the Roundup lawsuit?
Non-Hodgkin lymphoma is the primary cancer type covered in Roundup lawsuits.
Subtypes including diffuse large B-cell lymphoma, follicular lymphoma, and chronic lymphocytic leukemia are commonly accepted.
Other blood cancers may qualify on a case-by-case basis depending on evidence of glyphosate exposure.
What is the filing deadline for the Roundup lawsuit in 2026?
There is no single universal deadline; statutes of limitations vary by state and typically run two to five years.
The clock usually starts from the date you knew or should have known your cancer was linked to Roundup.
Consulting an attorney in 2026 is urgent if you were diagnosed in 2022, 2023, or 2024.
The Bottom Line for 2026 Roundup Claimants
The Roundup lawsuit update for 2026 is clear: this fight is ongoing, the money is real, and the window for filing is shrinking for some claimants. Bayer has paid billions and will pay billions more.
If you have an NHL diagnosis and a history of Roundup use, your claim deserves attention now. Waiting costs you options.
Gather your medical records, document your exposure history, and speak with a mass tort attorney who handles Roundup cases. The consultation is free, and the deadline clock does not stop.
